Cornerstone Planning Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6K Sell
63
-9
-13% -$3.34K ﹤0.01% 599
2026
Q1
$26.3K Buy
72
+19
+36% +$6.25K ﹤0.01% 587
2025
Q4
$18.1K Buy
53
+14
+36% +$4.73K ﹤0.01% 613
2025
Q3
$12.6K Buy
39
+17
+77% +$5.29K ﹤0.01% 710
2025
Q2
$6.08K Sell
22
-5
-19% -$2.01K ﹤0.01% 678
2025
Q1
$11.5K Buy
27
+21
+350% +$8.43K ﹤0.01% 530
2024
Q4
$2.47K Sell
6
-15
-71% -$6.28K ﹤0.01% 735
2024
Q3
$8.62K Buy
21
+3
+17% +$1.6K ﹤0.01% 444
2024
Q2
$9.42K Buy
18
+3
+20% +$1.59K ﹤0.01% 453
2024
Q1
$7.91K Hold
15
﹤0.01% 448
2023
Q4
$7.07K Sell
15
-1
-6% -$462 ﹤0.01% 484
2023
Q3
$6.97K Sell
16
-8
-33% -$3.63K ﹤0.01% 490
2023
Q2
$10.7K Buy
+24
New +$11.1K ﹤0.01% 631
2022
Q4
$15.8K Buy
+33
New +$16.8K 0.01% 495

Other funds holding ELV

Cornerstone Planning Group's ELV Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $3.34K and leaving 63 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Cornerstone Planning Group first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $26.3K in Q1 2026. 990 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cornerstone Planning Group held 63 shares of Elevance Health worth $24.6K as of Q2 2026.
  • Cornerstone Planning Group sold 9 Elevance Health shares in Q2 2026, an estimated $3.34K.
  • Elevance Health made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #599 holding.
  • Cornerstone Planning Group first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's Elevance Health position peaked at $26.3K in Q1 2026.
  • 990 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.